Report Company Directory
- Arrowhead Pharmaceuticals Inc "Initial INHBE obesity data potentially in..." by UBS AG
- US Biotechnology "Model Maintenance 4Q/FY24" Merle by UBS AG
- Ionis Pharmaceuticals Inc "Color from mgmt meeting" (Neutral) Merle by UBS AG
- Arrowhead Pharmaceuticals Inc "FY1Q25 Update: Early obesity program in the..." by UBS AG
- US Healthcare & Life Sciences "Policy expert views on the potential..." by UBS AG
- US Biotechnology "Day 2 in SF: ALNY, ALT, APLS, ARWR, ASND, MDGL, MRNA,..." by UBS AG
- US Pharmaceuticals & Biotechnology "2025 Outlook: Cautious on broader..." by UBS AG
- TRYNGOLZA Approved in FCS, Setting Up First Launch; sHTG Data, Lp(a) HORIZON, and Donidalorsen PDUFA 2025 Value Drivers by William Blair
- Arrowhead Pharmaceuticals Inc "SRPT collab a major positive" (Buy) Merle by UBS AG
- Sarepta Therapeutics "Collab with ARWR on muscle, lung, & CNS increases our..." by UBS AG